Clinical commentary: Report from the Society for Maternal-Fetal Medicine

Editorial

James E Ferguson 2nd. Am J Obstet Gynecol. 2005 May.

. 2005 May;192(5):1355-6.

doi: 10.1016/j.ajog.2005.03.020.

No abstract available

Similar articles

DISQ 8: Management of patients with an increased first-trimester Down syndrome screening risk and normal fetal karyotype.
Alfirevic Z. Alfirevic Z. Ultrasound Obstet Gynecol. 2008 Feb;31(2):232. doi: 10.1002/uog.5257. Ultrasound Obstet Gynecol. 2008. PMID: 18254160 No abstract available.
SURUSS in perspective.
Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. Wald NJ, et al. Semin Perinatol. 2005 Aug;29(4):225-35. doi: 10.1053/j.semperi.2005.05.006. Semin Perinatol. 2005. PMID: 16104673 Clinical Trial.
Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.
Wald NJ. Wald NJ. Prenat Diagn. 2010 Jul;30(7):619-21. doi: 10.1002/pd.2517. Prenat Diagn. 2010. PMID: 20572104 No abstract available.
[Prenatal screening for Down syndrome: from sequential to combined estimated risk].
Jouannic JM, Benifla JL. Jouannic JM, et al. Gynecol Obstet Fertil. 2006 Jun;34(6):467-9. doi: 10.1016/j.gyobfe.2006.04.006. Epub 2006 May 22. Gynecol Obstet Fertil. 2006. PMID: 16716636 Review. French. No abstract available.
The use of nuchal translucency in contemporary obstetric practice.
Said S, Malone FD. Said S, et al. Clin Obstet Gynecol. 2008 Mar;51(1):37-47. doi: 10.1097/GRF.0b013e318160f2ea. Clin Obstet Gynecol. 2008. PMID: 18303498 Review.